Expert Ratings for iRhythm Technologies
Within the last quarter, iRhythm Technologies (NASDAQ:IRTC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Analyst Ratings for iRhythm Technologies
Analysts have provided the following ratings for iRhythm Technologies (NASDAQ:IRTC) within the last quarter: Bullish Somewhat Bullish Indifferent…
Citigroup Maintains Neutral on iRhythm Technologies, Lowers Price Target to $110
Citigroup analyst Joanne Wuensch maintains iRhythm Technologies (NASDAQ:IRTC) with a Neutral and lowers the price target from $144 to $110.
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
iRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual Guidance
iRhythm Technologies Inc (NASDAQ:IRTC) posted an adjusted EPS loss of $(0.63), better than $(0.81) a year ago and the consensus…
UPDATE: iRhythm Technologies Q3 Adj. EPS $(0.63) Beats $(0.83) Estimate
iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.83) by 24.1 percent. This is a 22.22 percent increase over losses of $(0.81) per share
iRhythm Technologies’s Earnings Outlook
iRhythm Technologies (NASDAQ:IRTC) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement.
Analysts estimate that iRhythm Technologies will report an earnings per share (EPS) of $-0.83.
Truist Securities Maintains Buy on iRhythm Technologies, Lowers Price Target to $167
Truist Securities analyst David Rescott maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target from $185 to $167.
What 5 Analyst Ratings Have To Say About iRhythm Technologies
Within the last quarter, iRhythm Technologies (NASDAQ:IRTC) has observed the following analyst ratings:
Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $165
Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $172 to $165.